{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT06573450",
      "orgStudyIdInfo": {
        "id": "EBC biomarkers in CARAS"
      },
      "organization": {
        "fullName": "Henan University of Traditional Chinese Medicine",
        "class": "OTHER"
      },
      "briefTitle": "Exhaled Breath Condensate Biomarkers in CARAS",
      "officialTitle": "Preliminary Application and Evaluation of Exhaled Breath Condensate Biomarkers in Combined Allergic Rhinitis and Asthma Syndrome (CARAS)"
    },
    "statusModule": {
      "statusVerifiedDate": "2024-08",
      "overallStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2023-04-01",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2025-05-30",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2025-05-30",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2024-08-21",
      "studyFirstSubmitQcDate": "2024-08-23",
      "studyFirstPostDateStruct": {
        "date": "2024-08-27",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2024-08-27",
      "lastUpdatePostDateStruct": {
        "date": "2024-08-28",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Henan University of Traditional Chinese Medicine",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "To explore the differences in the expression of biomarkers in different sample types between the healthy population and different subgroups of the disease, and to screen for potential biomarkers in a more simple, direct and objective way. To screen the biomarkers that can be identified by CARAS Chinese medicine symptoms and different stages, and to provide a reference basis for individualised diagnosis and treatment of the disease."
    },
    "conditionsModule": {
      "conditions": [
        "Combined Allergic Rhinitis and Asthma Syndrome"
      ],
      "keywords": [
        "CARAS",
        "EBC",
        "Biomarkers",
        "Combination of disease and evidence"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": true,
      "targetDuration": "1 Day",
      "designInfo": {
        "observationalModel": "OTHER",
        "timePerspective": "CROSS_SECTIONAL"
      },
      "enrollmentInfo": {
        "count": 270,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "acute exacerbation CARAS",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "chronic persistence CARAS",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "clinical control CARAS",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "acute exacerbation BA",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "chronic persistence BA",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "clinical control BA",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "intermittent AR",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "persistent AR",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        },
        {
          "label": "healthy individuals",
          "description": "Thirty subjects were included. No intervention was performed and only relevant patient information, blood and exhaled breath condensate were collected.",
          "interventionNames": [
            "Other: questionnaire survey"
          ]
        }
      ],
      "interventions": [
        {
          "type": "OTHER",
          "name": "questionnaire survey",
          "description": "subjects fill out questionnaires",
          "armGroupLabels": [
            "acute exacerbation BA",
            "acute exacerbation CARAS",
            "chronic persistence BA",
            "chronic persistence CARAS",
            "clinical control BA",
            "clinical control CARAS",
            "healthy individuals",
            "intermittent AR",
            "persistent AR"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Interleukin-2、4、5、13 (IL-2、4、5、13)",
          "description": "Airway inflammation will be assessed using the IL-2、4、5、13.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Interferon-γ (IFN-γ)",
          "description": "Airway inflammation will be assessed using the IFN-γ.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Tumor necrosis factor-β (TNF-β)",
          "description": "Airway inflammation will be assessed using the TNF-β.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Eosinophil cationic proteins (ECP)",
          "description": "Airway inflammation will be assessed using the ECP.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Immunoglobulin E (IgE)",
          "description": "Airway inflammation will be assessed using the IgE.",
          "timeFrame": "Basline"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Fractional exhaled nitric oxide (FeNO)",
          "description": "Higher FeNO values indicate higher airway inflammation.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Forced expiratory volume in one second (FEV1)",
          "description": "Lung function will be assessed using the FEV1.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Forced vital capacity (FVC)",
          "description": "Lung function will be assessed using the FEV1.",
          "timeFrame": "Basline"
        },
        {
          "measure": "FVC as the percentage of the predicted value (FVC%)",
          "description": "Lung function will be assessed using the FVC%.",
          "timeFrame": "Basline"
        },
        {
          "measure": "Forced expiratory volume in one second / forced vital capacity (FEV1/FVC)",
          "description": "Lung function will be assessed using the FEV1/FVC.",
          "timeFrame": "Basline"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with AR, BA and CARAS who meet the Western medical diagnostic criteria;\n* Chinese medical evidence consistent with lung qi deficiency evidence, phlegm-heat congestion of the lung evidence, or wind-heat offending the lung evidence;\n* Age 18 to 80 years;\n* Voluntarily accepted the study and signed an informed consent form;\n* Not participated in other clinical studies within 1 month before enrollment.\n\nExclusion Criteria:\n\n* Patients with combined vasomotor rhinitis and eosinophilic non-allergic rhinitis, other non-allergic rhinitis diseases that can cause symptoms such as nasal congestion and runny nose;\n* Patients who are participating in other drug trials;\n* Patients with a combination of other serious systemic diseases;\n* Pregnant or lactating women;\n* Patients with confusion, disorders of consciousness, dementia, and various psychiatric disorders.",
      "healthyVolunteers": true,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "80 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ],
      "studyPopulation": "Allergic rhinitis (AR) is a common chronic inflammatory disease of the upper respiratory tract with paroxysmal sneezing, nasal congestion, watery nasal discharge and nasal itching as the main clinical symptoms. Bronchial asthma (BA) is a complex heterogeneous chronic inflammatory disease of the bronchi with recurrent symptoms of wheezing, shortness of breath, chest tightness, and coughing.AR usually coexists with BA, and about 70-90% of patients with asthma develop rhinitis, and about 40% of patients with rhinitis develop asthma. When AR and BA occur together, it is called combined allergic rhinitis and asthma syndrome (CARAS).",
      "samplingMethod": "NON_PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "centralContacts": [
        {
          "name": "Yang Xie",
          "role": "CONTACT",
          "phone": "13526621325",
          "email": "xieyanghn@163.com"
        }
      ],
      "locations": [
        {
          "facility": "The First Affiliated Hospital of Henan University of Chinese Medicine",
          "status": "RECRUITING",
          "city": "Henan",
          "state": "Zhengzhou",
          "country": "China",
          "contacts": [
            {
              "name": "Yang Xie, Ph.D",
              "role": "CONTACT",
              "phone": "+8613526621325",
              "email": "xieyanghn@163.com"
            }
          ],
          "geoPoint": {
            "lat": 39.46731,
            "lon": 115.13706
          }
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D011795",
          "term": "Surveys and Questionnaires"
        }
      ],
      "ancestors": [
        {
          "id": "D003625",
          "term": "Data Collection"
        },
        {
          "id": "D004812",
          "term": "Epidemiologic Methods"
        },
        {
          "id": "D008919",
          "term": "Investigative Techniques"
        },
        {
          "id": "D017531",
          "term": "Health Care Evaluation Mechanisms"
        },
        {
          "id": "D011787",
          "term": "Quality of Health Care"
        },
        {
          "id": "D017530",
          "term": "Health Care Quality, Access, and Evaluation"
        },
        {
          "id": "D011634",
          "term": "Public Health"
        },
        {
          "id": "D004778",
          "term": "Environment and Public Health"
        }
      ]
    }
  },
  "hasResults": false
}